Scientists have discovered an autoinflammatory illness brought on by mutations in the LYN gene, a crucial immune response regulator in both health and disease. The discovery, known as Lyn kinase-associated vasculopathy and liver fibrosis (LAVLI), provides insight into the possibility…
Category: Pharma News
According to senior CDSCO officials involved in the process, the risk-based inspections that the Central Drugs Standard Control Organization (CDSCO) scheduled for December of last year resulted in the cancellation of licences for 18 Indian pharmaceutical companies for producing fake…
In order to address pigmented and vascular under-eye dark circles, Entod Beauty London has recently introduced a unique gel serum called “Eyecirque Advance.” A powerful anti-vascular, anti-pigmentation, and anti-aging nanomolecule blend of tranexamic acid, alpha arbutin, glycolic acid, moringa extract,…
The best online pharmacy in India for super-specialty drugs, MrMed, has announced the release of its mobile app. The app, which is accessible on iOS and Android devices, makes it simple for patients and carers to get specialised medications at…
The cap on the trade margin for oxygen concentrators and five other medical devices that was imposed in 2021 has been further extended by the National Pharmaceutical Pricing Authority (NPPA) for three more months. Since the virus continues to pose…
The Department of Pharmaceuticals (DoP) may approach the Ministry of Finance for additional funding for the proposed new scheme for Promotion of Research and Innovation in Pharma-MedTech Sector (PRIP), with an outlay of Rs. 7,150 crore and the establishment of…
The second preplanned interim analysis of Baudax Bio, Inc.’s phase 2 trial of BX1000 for neuromuscular blockade (NMB) in patients undergoing elective surgery showed promising results. Baudax Bio, Inc. is a pharmaceutical company that specialises in developing novel products for…
The drug regulator has revoked the licences of several pharmaceutical enterprises operating in about 20 states nationwide due to concerns expressed by numerous public health experts and even certain pharmaceutical manufacturers regarding the prevalence of substandard quality medicines in the…
Patient advocacy groups are awaiting clarification on whether specific conditions will be covered by the National Policy of Rare Disorders (NPRD) 2021. This comes after the Union government recently allowed patients to receive treatment for six rare diseases by including…
The Rho kinase (ROCK) inhibitor NRL-1049, a potential treatment for people with cerebral cavernous malformations (CCM), a condition marked by abnormally enlarged capillary cavities in the brain and spinal cord, was dosed in the first two cohorts of the investigational…
